These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 28338619)

  • 1. Role and Function of A
    Ravani A; Vincenzi F; Bortoluzzi A; Padovan M; Pasquini S; Gessi S; Merighi S; Borea PA; Govoni M; Varani K
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28338619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.
    Varani K; Padovan M; Vincenzi F; Targa M; Trotta F; Govoni M; Borea PA
    Arthritis Res Ther; 2011; 13(6):R197. PubMed ID: 22146575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
    Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
    Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated.
    Vincenzi F; Corciulo C; Targa M; Merighi S; Gessi S; Casetta I; Gentile M; Granieri E; Borea PA; Varani K
    Eur J Immunol; 2013 Aug; 43(8):2206-16. PubMed ID: 23661562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts.
    Vincenzi F; Targa M; Corciulo C; Gessi S; Merighi S; Setti S; Cadossi R; Goldring MB; Borea PA; Varani K
    PLoS One; 2013; 8(5):e65561. PubMed ID: 23741498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
    Kreckler LM; Wan TC; Ge ZD; Auchampach JA
    J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of adenosine A
    Akhtari M; Vojdanian M; Javinani A; Ashraf-Ganjouei A; Jamshidi A; Mahmoudi M
    Cytokine; 2020 Apr; 128():154997. PubMed ID: 31978612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective and Potential of A2A and A3 Adenosine Receptors as Therapeutic Targets for the Treatment of Rheumatoid Arthritis.
    Pal Y; Bandyopadhyay N; Pal RS; Ahmed S; Bandopadhyay S
    Curr Pharm Des; 2019; 25(26):2859-2874. PubMed ID: 31291875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.
    Danning CL; Illei GG; Hitchon C; Greer MR; Boumpas DT; McInnes IB
    Arthritis Rheum; 2000 Jun; 43(6):1244-56. PubMed ID: 10857783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
    Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
    Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.
    Bortoluzzi A; Vincenzi F; Govoni M; Padovan M; Ravani A; Borea PA; Varani K
    Arthritis Res Ther; 2016 Aug; 18(1):192. PubMed ID: 27566294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
    Yang M; Soohoo D; Soelaiman S; Kalla R; Zablocki J; Chu N; Leung K; Yao L; Diamond I; Belardinelli L; Shryock JC
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):133-44. PubMed ID: 17310264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level.
    Madi L; Cohen S; Ochayin A; Bar-Yehuda S; Barer F; Fishman P
    J Rheumatol; 2007 Jan; 34(1):20-6. PubMed ID: 17216675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
    Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
    J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.
    Varani K; Vincenzi F; Tosi A; Targa M; Masieri FF; Ongaro A; De Mattei M; Massari L; Borea PA
    Br J Pharmacol; 2010 May; 160(1):101-15. PubMed ID: 20331607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts.
    Ongaro A; Varani K; Masieri FF; Pellati A; Massari L; Cadossi R; Vincenzi F; Borea PA; Fini M; Caruso A; De Mattei M
    J Cell Physiol; 2012 Jun; 227(6):2461-9. PubMed ID: 21830213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells.
    Hassanian SM; Dinarvand P; Rezaie AR
    J Cell Physiol; 2014 Sep; 229(9):1292-300. PubMed ID: 24477600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update.
    Guerrero A
    Curr Med Chem; 2018; 25(30):3597-3612. PubMed ID: 29532748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis.
    Appel H; Wu P; Scheer R; Kedor C; Sawitzki B; Thiel A; Radbruch A; Sieper J; Syrbe U
    J Rheumatol; 2011 Nov; 38(11):2445-51. PubMed ID: 21921098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.